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Abstract
Rett syndrome is a human neurodevelopmental disorder presenting almost exclusively in female
infants; it is the second most common cause of mental retardation in girls, after Down’s syndrome.
The identification in 1999 that mutation of the methyl-CpG-binding protein 2 (MECP2) gene on the
X chromosome causes Rett syndrome has led to a rapid increase in understanding of the
neurobiological basis of the disorder. However, much about the functional role of MeCP2, and the
cellular phenotype of both patients with Rett syndrome and mutant Mecp2 mouse models, remains
unclear.
Building on prior work in which we demonstrated that cortical layer 2/3 pyramidal neurons (primarily
interhemispheric “callosal projection neurons” (CPN)) have reduced dendritic complexity and
smaller somata in Mecp2-null mice, here we investigate whether Mecp2 loss-of-function affects
neuronal maturation cell-autonomously and/or non-cell-autonomously by creating physical
chimeras. We transplanted Mecp2-null or wild-type (wt) E17-18 cortical neuroblasts and immature
neurons from mice constitutively expressing enhanced green fluorescent protein (eGFP) into wt P2-3
mouse cortices to generate chimeric cortices. Mecp2-null layer 2/3 pyramidal neurons in both
Mecp2-null and wt neonatal cortices exhibit equivalent reduction in dendritic complexity, and are
smaller than transplanted wt neurons, independent of recipient environment. These results indicate
that the phenotype of Mecp2-null pyramidal neurons results largely from cell-autonomous
mechanisms, with additional non-cell-autonomous effects. Dysregulation of MeCP2 target genes in
individual neuronal populations such as CPN is likely centrally involved in Rett syndrome
pathogenesis. Our results indicating MeCP2 function in the centrally affected projection neuron
population of CPN themselves provide a foundation and motivation for identification of
transcriptionally regulated MeCP2 target genes in developing CPN.
© 2009 Elsevier Inc. All rights reserved.
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Introduction
Rett syndrome is a neurodevelopmental disorder presenting almost exclusively in girls, with
a prevalence rate of one in 10,000 to 15,000 female births (Bienvenu and Chelly, 2006; Francke,
2006; Hagberg, 2002; Kishi and Macklis, 2005; Kriaucionis and Bird, 2003; Moretti and
Zoghbi, 2006; Rett, 1966). After Down’s syndrome, Rett syndrome is the second most common
cause of mental retardation in girls (Ellaway and Christodoulou, 2001). Children with Rett
syndrome exhibit mental retardation, autistic features, and a breathing disorder after 6-18
months of relatively normal development. In 1999, it was discovered that loss-of-function
mutation of the methyl-CpG-binding protein 2 (MECP2) gene on the X chromosome causes
Rett syndrome (Amir et al., 1999). MeCP2 is typically referred to as a transcriptional repressor
that selectively binds methyl CpG dinucleotides in the mammalian genome, mediating
transcriptional repression, though a recent report describes transcriptional activator activity
(Chahrour et al., 2008). It is becoming widely accepted that many transcriptional regulators
can function as both repressors and activators, depending on context and co-factors.
Mecp2-deficient mice display several phenotypic characteristics that mimic symptoms of Rett
syndrome patients, offering a valuable investigative tool as a murine disease model (Chen et
al., 2001; Guy et al., 2001; Lawson-Yuen et al., 2007; Pelka et al., 2006; Shahbazian et al.,
2002). These phenotypes are known to be due to the loss of MeCP2 function in the central
nervous system (CNS), because specific deletion of Mecp2 in the brain mimics the germline
loss of Mecp2 (Chen et al., 2001; Guy et al., 2001). Importantly, recent evidence clearly
indicates that gene silencing mechanisms and target genes of MeCP2 are quite different
between neural and non-neural cells (Lunyak et al., 2002). MeCP2 expression increases with
maturity in the developing cortex, and MeCP2 is broadly expressed in the adult mouse brain.
While MeCP2 begins expression as neurons emerge from progenitors, and is strongly
expressed in mature neurons (Kishi and Macklis, 2004), recent studies report that MeCP2 is
also expressed in astroglia and oligodendroglia at low levels (Ballas et al., 2009; Maezawa et
al., 2009). Despite the broad expression of MeCP2 at high levels in neurons, and at lower levels
in glia of the CNS, recent results indicate that loss of Mecp2 function has distinct influences
on different cell types (Adachi et al., 2009; Fyffe et al., 2008; Kishi and Macklis, 2004).
Therefore, in order to understand the pathogenesis of Rett syndrome, it is critical to investigate
MeCP2 function specifically in affected populations of CNS neurons. This approach has
provided insight into MeCP2 function, including MeCP2 target genes in neurons (Bienvenu
and Chelly, 2006), as well as activity-dependent Bdnf regulation by MeCP2 (Chen et al.,
2003; Martinowich et al., 2003). However, due to lack of accurate in vitro models, and the
subtlety of the in vivo phenotype, it has remained unclear whether the neuronal phenotype in
the absence of MeCP2 function is due to lack of Mecp2 in the affected neurons themselves
(cell-autonomous mechanisms) and/or due to lack of Mecp2 in surrounding cells (non-cell-
autonomous mechanisms).
In the experiments reported here, we investigate whether loss of Mecp2 function affects
neuronal maturation largely cell-autonomously or non-cell-autonomously. Previous studies
from our lab and others have shown that MeCP2 functions in neocortical neuronal maturation
and dendritic development (Fukuda et al., 2005; Kishi and Macklis, 2004). In particular, Golgi
staining, which allows visualization of the morphology of individual neurons, showed that
Mecp2-null layer 2/3 pyramidal neurons (predominantly interhemispheric CPN) specifically
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texhibit reduced dendritic complexity and smaller somata than those in wt mice (Kishi and
Macklis, 2004). Similar findings have been reported in human postmortem Rett syndrome
brains (Armstrong et al., 1995; Bauman et al., 1995; Schule et al., 2008). Appropriate callosal
connectivity is thought to underlie associative aspects of higher cognition, and has been
centrally implicated in autism spectrum disorders (Egaas et al., 1995). To investigate whether
these deficits in CPN development are due to MeCP2 transcriptional dysregulation within the
neurons themselves, we perfomed a series of neuronal transplantation experiments using eGFP-
labeled wt and Mecp2-null neurons, generating physical chimeras in both wt and Mecp2-null
recipients. Our results demonstrate that transplanted Mecp2-null layer 2/3 pyramidal neurons
are smaller than and have reduced dendritic complexity compared with transplanted wt neurons
in the wt environment, indicating that the mechanisms underlying abnormal dendritic
development of CPN in Mecp2-null mice are largely cell-autonomous.
Materials and Methods
Animals
All mouse experimental protocols were approved by the institutional animal care and use
committee, and adhere to NIH guidelines. Wild-type C57BL/6 mice were purchased from
Charles River Laboratories (Wilmington, MA). GFP-expressing transgenic mice (C57BL/6-
Tg(ACTB-EGFP)1Osb/J) (Okabe et al., 1997) were purchased from the Jackson Laboratories
(Bar Harbor, ME). This transgenic mouse line with an “enhanced” GFP (eGFP) cDNA under
the control of a chicken beta-actin promoter and cytomegalovirus enhancer expresses eGFP
in all tissues except erythrocytes and hair (Okabe et al., 1997). Female Mecp2 heterozygous
mice were generously provided by the laboratory of Dr. Rudolf Jaenisch (Chen et al., 2001).
To obtain Mecp2-null hemizygous male mice (non-eGFP or eGFP), we crossed female
heterozygotes with wt male C57BL/6 or male eGFP transgenic mice. For timed gestations,
midnight prior to the morning upon which the vaginal plug was observed was defined as day
0. The genotypes of Mecp2 mutant mice were identified by PCR on tail genomic DNA as
described previously (Chen et al., 2001; Kishi and Macklis, 2004). The genotypes of GFP
transgenic mice were determined using fluorescence excitation.
Transplantation to produce physical chimeras
We crossed female Mecp2 heterozygotes with wt male C57BL/6 or male eGFP transgenic mice
and obtained embryonic day 17-18 (E17-18) eGFP-labeled wt or eGFP-labeled Mecp2-null
embryos as donor cell sources, and postnatal day 2-3 (P2-3) wt or Mecp2-null neonatal mice
as recipients on the same day. On the day of transplantation, eGFP-positive E17-18 embryos
were selected by fluorescence excitation, tails were collected for genotyping, and individual
cortices were dissected out for donor neuroblast dissociation. Cortices were dissected in cold
dissociation medium (20 mM glucose, 0.8 mM kynurenic acid, 0.05 mM DL-2-Amino-5-
phosphonopentanoic acid (APV), 50 U/ml penicillin–0.05 mg/ml streptomycin, 0.09 M
Na2SO4, 0.03 M K2SO4, and 0.014 M MgCl2), and enzymatically digested in dissociation
medium containing 0.16 mg/l L-cysteine HCl and 10 U/ml papain (Worthington, Lakewood,
NJ) at 37°C for 15 min, followed by rinsing with iced OptiMem (Life Technologies,
Gaithersburg, MD) containing 20 mM glucose, 2.5% fetal bovine serum (Invitrogen, Carlsbad,
CA), and both 0.4 mM kynurenic acid and 0.025 mM APV to protect against glutamate-induced
neurotoxicity (Catapano et al., 2001). Cortices were mechanically dissociated by gentle
trituration to create a single cell suspension. Dissociated cortical cells were resuspended at
5×106 cells/ml. P2-3 wt or Mecp2-null mice were anesthetized by hypothermia, and ~10,000
total dissociated cortical cells were transplanted into the neocortex at 10 sites (~1,000 cells/
site) with a digitally controlled oocyte injector (Nanoject II; Drummond Scientific, Broomall,
PA) using pulled glass micropipettes with beveled tip diameter of 50-60  m. Dissociated cells
were microinjected in ten “columns” from 300  m deep to the pial surface, with the 10
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ttransplantation sites spaced evenly throughout the parietal cortex. Following monitored
recovery, the pups were returned to their mothers. At 8 weeks of age, the transplanted (physical
chimera) mice were perfused, and brains were sectioned for immunocytochemistry.
Histology, immunocytochemistry, and Sholl analysis
Following deep anesthesia with Avertin, brains were fixed by transcardial perfusion with 0.1
M phosphate-buffered saline (PBS) with 10 U/ml heparin, pH 7.4, followed by 4%
paraformaldehyde (PFA) in PBS buffer. Brains were postfixed in 4% PFA overnight and
sectioned at a thickness of 50  m with a vibrating microtome (Leica). Vibrating microtome
sections were collected into PBS, incubated in blocking solution (PBS, 1% BSA, 3% goat
serum, and 0.3% TritonX-100) for 30 min at room temperature, then incubated in primary
antibody, chick anti-GFP IgG (1:1,500, Chemicon, Temecula, CA), overnight at 4°C. Sections
were washed three times in PBS for 10 min, and incubated in Alexa 488 goat anti-chick IgG
antibody (1:750, Invitrogen) for 2 h at room temperature. Sections were mounted on glass
slides after washing with PBS and deionized water.
While most of the transplanted neurons remained in the injection sites and extended their
dendrites locally, a subpopulation of transplanted neurons migrated away from the injection
sites and extended their dendrites, integrating within the recipient brains. To avoid assessing
transplanted neurons that remained in the injection sites as heterotopias, only GFP-positive
transplanted layer 2/3 pyramidal neurons more than 200  m from the injection sites were
systematically selected for Sholl analysis (Kishi and Macklis, 2004; Sholl, 1953). Images were
captured using a fluorescence microscope (Nikon E1000) with high numerical aperture optics
and a cooled CCD camera (Q-Imaging) running Openlab software (Improvision, Lexington,
MA) to cover entire dendritic arbors. Series of images were reconstructed using Photoshop
(Adobe, San Jose, CA). Concentric circles with 20  m radius increments were superimposed
around the center of reconstructed somas, and the number of dendrites crossing each circle was
counted. Soma sizes were measured using Openlab software. Statistical analysis was performed
using an unpaired one-tailed t-test. All results are presented as the mean ± standard error of
the mean (SEM).
Results
Our previous data showed that layer 2/3 pyramidal neurons (predominantly interhemispheric
CPN) in Mecp2-null mice have reduced dendritic complexity and smaller somata than those
in wt mice (Kishi and Macklis, 2004). These results indicate that Mecp2 is involved in neuronal
maturation and/or maintenance of CPN. The specific CPN phenotype indicates that layer 2/3
pyramidal/callosal projection neurons are an ideal target cell population in which to investigate
MeCP2 function.
To further investigate whether these abnormalities arise from cell-autonomous mechanisms,
we performed neuronal transplantation experiments using eGFP-labeled neurons to generate
physical chimeras and analyzed the neuronal dendritic complexity of layer 2/3 pyramidal
neurons (Fig. 1). We crossed female Mecp2 heterozygous mice with male eGFP-expressing
transgenic mice to obtain Mecp2-null;eGFP+/- E17-18 neuroblasts for transplantation into
P2-3 wt cortex, and wt;eGFP+/- neuroblasts for transplantation into Mecp2-null cortex.
Transplantation of wt;eGFP+/- neuroblasts into wt cortex and Mecp2-null;eGFP+/- neuroblasts
into Mecp2-null cortex served as controls. E17-18 corresponds to the peak of layer 2/3 neuron
migration, and early differentiation (Floeter and Jones, 1985), and neonatal P2-3 cortex readily
integrates exogenously transplanted neuroblasts and immature neurons into cortical circuitry
(Brustle et al., 1998;Gates et al., 2000). Because our previous results demonstrate that reduction
in dendritic complexity of Mecp2-null layer 2/3 pyramidal neurons is statistically evident at 8
weeks of age, but not at 2 weeks of age (Kishi and Macklis, 2004), we imaged the extent of
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tdendritic arborization of the GFP-labeled pyramidal neurons in layer 2/3, and reconstructed
the entire dendritic morphology at 8 weeks of age (Figs. 2A and B). We found no substantial
difference in survival of transplanted neurons among the four different transplantation
experiments (WT-to-WT, n=3; KO-to-WT, n=5; WT-to-KO n= 4; KO-to-KO, n= 4). While
most of the transplanted neurons remained in the injection sites and formed heterotopias, a
subpopulation of transplanted neurons migrated away from the injection sites, and extended
their dendrites, integrating within the recipient brains. To avoid assessing transplanted neurons
that remained as heterotopias at the injection sites, we selected for analysis only GFP-positive
transplanted layer 2/3 pyramidal neurons more than 200  m from the injection sites. Using the
reconstructed images, we analyzed dendritic arborization via Sholl analysis by counting the
number of dendrites crossing concentric circles originating from the cell body, and we analyzed
soma size by measuring cell body area (Figs. 2C and D).
After eGFP-labeled wt or Mecp2-null neuroblasts were transplanted into wt cortex,
transplanted Mecp2-null layer 2/3 pyramidal neurons displayed significantly less complex
dendritic arborization (Fig. 2E) than transplanted wt neurons (wt, n=14 from 3 mice; Mecp2-
null, n=25 from 5 mice). These results indicate that the wt environment does not rescue the
phenotype of Mecp2-null pyramidal neurons, and that these deficits result predominantly via
cell-autonomous mechanisms.
In contrast, to investigate a potential non-cell-autonomous contribution of Mecp2 function, we
analyzed dendritic arborization at 8 weeks of age after transplantation of wt E17-18 eGFP-
labeled neuroblasts into either wt or Mecp2-null cortex (Fig. 2F). While there were no
significant differences in proximal dendritic complexity (20-120  m from soma) between wt
layer 2/3 pyramidal neurons in wt or Mecp2-null cortex, we found that distal dendritic
complexity (120-200  m from soma) of wt neurons in Mecp2-null cortex is slightly reduced
compared with that of wt neurons in wt cortex (wt, n=14 from 3 mice; Mecp2-null, n=15 from
4 mice) (Fig. 2F). These results indicate that the Mecp2-null environment contributes in part
to the neuronal phenotype.
To further investigate the relative contributions of cell-autonomous vs. non-cell-autonomous
mechanisms in affecting dendritic complexity in Mecp2-null CPN, we compared the dendritic
arborization of Mecp2-null layer 2/3 pyramidal neurons in Mecp2-null cortex (n=22 from 4
mice) to that of Mecp2-null neurons in wt cortex (n=25 from 5 mice). We found that there was
no additional contribution of the Mecp2-null environment to the phenotype of Mecp2-null
neurons (Fig. 2G). These three paired comparisons indicate that lack of Mecp2 in neurons
themselves is the predominant cause of the Mecp2 mutant phenotype in cortical layer 2/3
projection neurons, though the Mecp2-null environment also contributes to the phenotype.
In addition to the dendritic phenotype of Mecp2-null pyramidal neurons, we also analyzed
soma size of transplanted neurons in the four transplantation paradigms (Fig. 2H). In contrast
to the dendritic phenotype, soma size of wt neurons in the Mecp2-null cortex, and of Mecp2-
null neurons in wt cortex, was significantly reduced compared to that of wt neurons in wt
cortex, and was indistinguishable from that of Mecp2-null neurons in Mecp2-null cortex (WT-
to-WT, n=14 from 3 mice; KO-to-WT, n=25 from 5 mice; WT-to-KO, n=15 from 4 mice; KO-
to-KO, n=22 from 4 mice). Unlike the dendritic morphology results indicating predominantly
cell-autonomous MeCP2 function in dendritic arborization, these data indicate that Mecp2
mutation affects soma size via a combination of cell-autonomous and non-cell-autonomous
mechanisms.
To further examine the nature of the reduction in dendritic complexity in Mecp2-null neurons
in detail, we analyzed the number of primary and secondary dendrites (Fig. 3), as well as the
dendritic complexity of apical and basal dendrites of transplanted layer 2/3 pyramidal neurons
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t(Fig. 4). The dendritic tree of a pyramidal neuron can be broadly subdivided into two distinct
classes of dendrites: basal and apical dendrites, which extend from the base and the apex of
the soma, respectively (Spruston, 2008). Basal and proximal apical dendrites receive input
from layer 4 neurons, and also receive local-circuit excitation, while the apical tufts of layer
2/3 pyramidal neurons receive input from other cortical areas, and also receive non-specific
thalamic input. Consistent with and further extending the results above, Mecp2-null neurons
in wt cortex have significantly fewer primary and secondary dendrites (Figs. 3A and B), and
significantly less complex apical and basal dendrites than transplanted wt neurons in wt cortex
(Figs 4A and B). These results indicate a major cell-autonomous component to the observed
abnormalities of dendritic complexity in the absence of MeCP2 function. Interestingly,
however, dendritic arborization of wt neurons in Mecp2-null cortex is modestly reduced
compared with that of wt neurons in wt cortex (Figs. 4C and D), indicating an additional (but
more limited) non-cell-autonomous effect on dendritic complexity. We also detected a modest
reduction of secondary dendrites (Fig. 3B) and apical dendritic complexity of Mecp2-null
neurons transplanted into wt cortex (Fig. 4E), compared with those of Mecp2-null neurons in
Mecp2-null cortex, indicating that their presence in a wt environment is detrimental to the
dendritic complexity of Mecp2-null neurons under certain conditions. In combination with the
observed modest increase in dendritic arborization of wt neurons in Mecp2-null cortex 20  m
from the soma compared with that of wt neurons in wt cortex (Fig. 4C), this finding suggests
the possibility that competition between transplanted Mecp2-null neurons and neighboring wt
neurons might further detrimentally affect the dendritic morphology of transplanted Mecp2-
null neurons. While the substantial (cell-autonomous) reduction in the ability of Mecp2-null
transplanted neurons to form and/or mature dendrites might not be a competitive disadvantage
when surrounded by similarly affected Mecp2-null neurons in Mecp2-null mice, such cell-
autonomous reduction in dendritic complexity might be predicted to be a competitive
disadvantage compared to neighboring wt neurons in wt mice.
Taken together, these results indicate that the striking decrease in CPN dendritic complexity
in Mecp2-null cerebral cortex is caused predominantly by cell-autonomous mechanisms, with
additional non-cell-autonomous effects, and that loss of Mecp2 function reduces dendritic
complexity of both apical and basal dendrites in vivo.
Discussion
These experiments using neuroblast transplantation to produce physical chimeras demonstrate
that the decreased dendritic arborization that we previously observed in Mecp2-null callosal
projection neurons is largely due to cell-autonomous mechanisms, indicating that Mecp2 acts
predominantly cell-autonomously during maturation of these neurons.
Multiple studies using Mecp2 heterozygous female mice are consistent with our results and
interpretation (Belichenko et al., 2009; Braunschweig et al., 2004; Young and Zoghbi, 2004).
A previous study on X chromosome inactivation patterns in the brain showed that truncated
Mecp2 heterozygous mice have a predominant population of Purkinje cells in which the X
chromosome bearing the wt allele is the active one (Young and Zoghbi, 2004). The authors
confirmed these results using cultured hippocampal neurons, and suggested that the skewed X
chromosome inactivation patterns are due to selective survival of neurons carrying the wt
Mecp2 allele. The interpretation that wt Mecp2 expression confers survival advantage in
neurons is consistent with its effect being largely cell-autonomous. However, another study of
female Mecp2 heterozygous mice using laser scanning cytometry suggests that Mecp2-null
neurons alter the expression level of MeCP2 in neighboring wt Mecp2-expressing neurons in
a non-cell-autonomous manner (Braunschweig et al., 2004). However, this population-based
conclusion is uncertain, since each neuron in the brains of Mecp2 heterozygous mice expresses
either wt or mutant MeCP2 at random.
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tIn the experiments we report here, we used either wt or Mecp2-null recipient cortex as an
environment in which to directly and clearly address the possibility and relative contribution
of non-cell-autonomous effects, thus avoiding difficulties associated with Mecp2
heterozygosity. In addition, because we specifically analyzed layer 2/3 pyramidal neurons,
which are the most severely affected cell population in the cortex of Mecp2-null mice in
vivo, we can interpret the results in a relevant neuronal population, without confounding factors
often associated with in vitro systems.
The size and shape of a neuron’s dendritic arbors are influenced by both cell-intrinsic and cell-
extrinsic factors (Miller and Kaplan, 2003). It is known that neuronal activity is a key signal
for dendrite formation. Neuronal activation by stimuli such as neurotransmitters or
neurotrophins (e.g. BDNF) directly or indirectly activates the Ras-MEK-ERK signaling
pathway by increasing local Ca2+ concentration, leading to CaMKII activation. Simultaneous
activation of CaMKII and ERK enhances MAP2-microtubule interactions and stabilizes
dendritic formation. Interestingly, previous studies showed that MeCP2 binds to the promoter
region of the Bdnf gene, and MeCP2 dissociates from the promoter upon stimulation, via either
phosphorylation of MeCP2 or demethylation of methyl-CpG in the promoter region, indicating
a tight relationship between dendrite formation and MeCP2-regulated Bdnf expression (Chen
et al., 2003; Martinowich et al., 2003). A recent study showed that neuronal activity and
subsequent calcium influx trigger the de novo phosphorylation of MeCP2 at serine 421 by a
CaMKII-dependent mechanism (Zhou et al., 2006). These findings further support the existing
interpretation that MeCP2 is involved in dendrite and synapse formation and maturation (Asaka
et al., 2006; Chao et al., 2007; Fukuda et al., 2005; Kishi and Macklis, 2004; Nelson et al.,
2006; Smrt et al., 2007), and the idea that dysregulation of BDNF might be one non-cell-
autonomous cause of reduced dendritic complexity in Mecp2-null cerebral cortex.
Very recently, two studies using in vitro co-culture report that MeCP2 is also expressed in
astroglia and oligodendroglia at low levels, and that Mecp2-deficient astroglia non-cell-
autonomously affect neuronal dendritic growth via aberrant secretion of soluble factors (Ballas
et al., 2009; Maezawa et al., 2009). These in vitro results are consistent with the partially non-
cell-autonomous effects of Mecp2 observed in our in vivo experiments, suggesting that
potentially negative effects of Mecp2-null astroglia and/or other elements might be responsible
for the observed reduction in dendritic complexity and soma size of wt neurons in Mecp2-null
cortex. While the in vitro studies noted above emphasize non-cell-autonomous MeCP2
function, they do not show evidence of cell-autonomous MeCP2 function. While our in vivo
experiments clearly show that integration within a wt environment does not improve the
dendritic phenotype of transplanted Mecp2-null neurons, one of the studies noted above
reported that conditioned medium from wt astroglia improved the dendritic morphology of
Mecp2-null neurons in their co-culture system (Ballas et al., 2009). While physical chimeric
analysis by transplantation (widely and successfully used as a developmental biology approach
that yields complex, in vivo insights) can directly address MeCP2 function in vivo, in vitro co-
culture systems can also potentially offer additional insights into MeCP2 function by
eliminating additional complexity present in vivo (e.g. functional compensation). Although in
vivo chimeric analysis is likely to mimic real in vivo conditions more closely than in vitro co-
culture systems, we think it likely that the transplantation procedures themselves and/or the
environment of donor cells before E17 will also affect dendritic maturation later (thus the four
distinct and inter-controlled transplantation experiments). Further studies will be useful to
further elucidate the relative contributions of cell-autonomous and non-cell-autonomous
mechanisms.
Taken together, the data presented here indicate that Mecp2 functions largely cell-
autonomously in neuronal maturation and dendritic arborization of the centrally affected
projection neuron population of layer 2/3 CPN. These findings provide both foundation and
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tmotivation for identification of MeCP2 regulated target genes that might be centrally involved
in Rett syndrome pathogenesis. Previous studies have revealed that, although Mecp2 is
expressed in all layers of the neocortex (Fukuda et al., 2005; Kishi and Macklis, 2004), layer
2/3 cortical neurons are most severely affected by mutation of Mecp2. Additionally, recent
studies reveal that each neuronal subtype has a unique and specific molecular developmental
program (Alcamo et al., 2008; Arlotta et al., 2005; Azim et al., 2009a; Azim et al., 2009b;
Britanova et al., 2008; Chen et al., 2004; Chen et al., 2005; Joshi et al., 2008; Lai et al.,
2008; Molyneaux et al., 2005; Molyneaux et al., 2007; Ozdinler and Macklis, 2006), suggesting
the likelihood that loss of Mecp2 function might specifically, subtly, and neuron type-
specifically disrupt molecular control of CPN maturation (and, by extension, of other neuron
populations). Further investigation can now be pursued to identify new MeCP2 target genes
that function cell-autonomously and specifically in the differentiation and maturation of the
CPN subtype (in particular, in dendritic development, arborization, and maintenance), in order
to further elucidate the cellular and downstream molecular bases and neuropathogenesis of
Rett syndrome.
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tFig. 1. Schematic of generation and analysis of physical chimeras; transplantation of GFP-labeled
wt or Mecp2-null neuroblasts into wt or Mecp2-null cortex
To investigate whether Mecp2-null abnormalities are cell-autonomous, neuronal
transplantation experiments using eGFP labeled neurons were performed, generating physical
chimeric cortices. (a): Mecp2 heterozygous mice were crossed with eGFP-expressing
transgenic mice to generate either Mecp2-null;eGFP+/- or wt;eGFP+/- E17-18 neuroblasts.
(b): These eGFP-expressing neuroblasts were transplanted into either wt or Mecp2-null cortex
at P2-3, respectively. Wt;eGFP+/- neuroblasts transplanted into wt cortex and Mecp2-
null;eGFP+/- neuroblasts into Mecp2-null cortex served as controls. E17-18 is the peak of layer
2/3 neuron birth, migration, and early differentiation. Neonatal P2-3 cortex readily integrates
exogenously transplanted neuroblasts and immature neurons into brain circuitry. (c): Neuronal
phenotype was examined at 8 weeks, an age when the Mecp2-null phenotype of decreased
dendritic complexity in layer 2/3 pyramidal neurons is readily apparent.
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tFig. 2. Reduced dendritic complexity of Mecp2-null pyramidal neurons is largely due to cell-
autonomous mechanisms
(A - D) Examples of Sholl analysis of transplanted layer 2/3 pyramidal neurons. GFP-labeled
E17-18 wt or Mecp2-null neuroblasts were transplanted into P2-3 wt cortex. Eight weeks later,
the mice were perfused, and the transplanted GFP-labeled layer 2/3 wt (A) or Mecp2-null (B)
pyramidal neurons were immunocytochemically visualized using an anti-GFP antibody. (C
and D) Drawings of layer 2/3 pyramidal neurons from A in (C) and from B in (D). Concentric
circles in 20  m radius increments for Sholl analysis are superimposed. (E – G) Dendritic
arborization was measured by Sholl analysis of transplanted GFP-labeled layer 2/3 pyramidal
neurons. Transplanted Mecp2-null layer 2/3 pyramidal neurons have less complex dendritic
arborization (E) in the wt recipient environment than that of transplanted wt neurons in the wt
recipient environment (WT neurons, n=14 from 3 mice; KO neurons, n=25 from 5 mice). We
also analyzed dendritic arborization (F) of wt GFP-labeled layer 2/3 pyramidal neurons
transplanted into either wt or Mecp2-null cortex (WT cortex, n=14 from 3 mice; KO cortex,
n=15 from 4 mice), and dendritic arborization (G) of Mecp2-null layer 2/3 pyramidal neurons
transplanted into either wt or Mecp2-null environment (WT cortex, n=25 from 5 mice; KO
cortex, n=22 from 4 mice). (H) Soma size was measured in transplanted GFP labeled layer 2/3
pyramidal neurons in the four transplantation paradigms (WT-to-WT, n=14 from 3 mice; KO-
to-WT, n=25 from 5 mice; WT-to-KO, n=15 from 4 mice; KO-to-KO, n=22 from 4 mice).
Scale bars, 100  m in A and B. Values represent the mean ± standard error of the mean (SEM).
*p < 0.05, **p < 0.01, Student’s t-Test. WT; wild type, KO; Mecp2 -/y.
Kishi and Macklis Page 13
Exp Neurol. Author manuscript; available in PMC 2011 March 1.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFig. 3. Reduction in primary and secondary dendrites of Mecp2-null pyramidal neurons cell-
autonomously contributes to the reduced dendritic phenotype
(A and B) The numbers of primary (A) and secondary (B) dendrites per transplanted layer 2/3
neuron were analyzed in the four transplantation paradigms at 8 weeks of age: wt neurons in
wt cortex (blue, n=14 from 3 mice); Mecp2-null neurons in wt cortex (red, n=25 from 5 mice);
wt neurons in Mecp2-null cortex (orange, n=15 from 4 mice); and Mecp2-null neurons in
Mecp2-null cortex (green, n=22 from 4 mice). The numbers of both primary and secondary
dendrites of Mecp2-null neurons in wt cortex are significantly reduced compared to those of
wt neurons in wt cortex, reinforcing that the phenotype caused by Mecp2 mutations is through
predominantly cell-autonomous mechanisms. However, we also found that the number of
secondary dendrites of Mecp2-null neurons in wt cortex is modestly less than that of Mecp2-
null neurons in Mecp2-null cortex, suggesting the possibility that competition between
transplanted Mecp2-null neurons and neighboring wt neurons might further detrimentally
affect the dendritic morphology of transplanted Mecp2-null neurons. Values represent the mean
± SEM. *p < 0.05, **p < 0.01, Student’s t-Test. WT; wild type, KO; Mecp2 -/y.
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tFig. 4. Mutation of Mecp2 cell-autonomously reduces both apical and basal dendritic complexity
Apical (A, C, and E) and basal (B, D, and F) dendritic arborization of transplanted layer 2/3
neurons were analyzed in the four transplantation paradigms at 8 weeks of age: wt neurons in
wt cortex (blue, n=14 from 3 mice); Mecp2-null neurons in wt cortex (red, n=25 from 5 mice);
wt neurons in Mecp2-null cortex (orange, n=15 from 4 mice); and Mecp2-null neurons in
Mecp2-null cortex (green, n=22 from 4 mice). Consistent with the analysis of global dendritic
arborization, mutation of Mecp2 reduced both apical (A) and basal (B) dendritic arborization
even in wt cortex, reconfirming that the deficits result largely via cell-autonomous mechanisms.
Interestingly, we found that apical dendritic arborization of Mecp2-null neurons in wt cortex
is reduced compared with that of Mecp2-null neurons in Mecp2-null cortex (E), again
suggesting the possibility that competition between transplanted Mecp2-null neurons and
neighboring wt neurons might further detrimentally affect the dendritic morphology of
transplanted Mecp2-null neurons. Values represent the mean ± SEM. *p < 0.05, **p < 0.01,
Student’s t-Test. WT; wild type, KO; Mecp2 -/y.
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